↓ Skip to main content

Evaluation of the cost effectiveness of exenatide versus insulin glargine in patients with sub-optimally controlled Type 2 diabetes in the United Kingdom

Overview of attention for article published in Cardiovascular Diabetology, August 2008
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
105 Mendeley
citeulike
2 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Evaluation of the cost effectiveness of exenatide versus insulin glargine in patients with sub-optimally controlled Type 2 diabetes in the United Kingdom
Published in
Cardiovascular Diabetology, August 2008
DOI 10.1186/1475-2840-7-24
Pubmed ID
Authors

Anette Woehl, Mark Evans, Anthony P Tetlow, Philip McEwan

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 105 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Italy 2 2%
Ireland 1 <1%
Brazil 1 <1%
Canada 1 <1%
Belgium 1 <1%
United States 1 <1%
Unknown 98 93%

Demographic breakdown

Readers by professional status Count As %
Student > Master 25 24%
Researcher 24 23%
Student > Ph. D. Student 11 10%
Other 10 10%
Student > Bachelor 7 7%
Other 16 15%
Unknown 12 11%
Readers by discipline Count As %
Medicine and Dentistry 52 50%
Pharmacology, Toxicology and Pharmaceutical Science 9 9%
Economics, Econometrics and Finance 6 6%
Agricultural and Biological Sciences 5 5%
Biochemistry, Genetics and Molecular Biology 4 4%
Other 13 12%
Unknown 16 15%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 September 2015.
All research outputs
#4,836,328
of 25,374,917 outputs
Outputs from Cardiovascular Diabetology
#384
of 1,654 outputs
Outputs of similar age
#17,657
of 101,321 outputs
Outputs of similar age from Cardiovascular Diabetology
#1
of 1 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,654 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.5. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 101,321 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them